Dasatinib monohydrate

• Description :

  Dasatinib is an oral dual BCR/ABL and Src family tyrosine kinase inhibitor approved for use in patients with chronic myelogenous leukemia (CML) .

• Stability :

  ≥ 2 years

• Purity :

  >98% (HPLC)

• Weight :

  506.03

• Molecular Formula :

  C22H28ClN7O3S

• Notes :

  Research use only, not for human use.

• Receptor :

  Abl| c-Kit (D816V) | c-Kit (wt) | EphA2| Src

• CAS Number :

  863127-77-9